In the present study, chitosan-decorated multiple nanoemulsion (MNE) was formulated using a two-step emulsification process. The formulated multiple nanoemuslion was evaluated physiochemically for its size and zeta potential, surface morphology, creaming and cracking, viscosity and pH. A Franz diffusion cell apparatus was used to carry out in vitro drug-release and permeation studies. The formulated nanoemulsion showed uniform droplet size and zeta potential. The pH and viscosity of the formulated emulsion were in the range of and suitable for topical delivery. The drug contents of the simple nanoemulsion (SNE), the chitosan-decorated nanoemulsion (CNE) and the MNE were 71 ± 2%, 82 ± 2% and 90 ± 2%, respectively. The formulated MNE showed controlled release of itraconazole as compared with that of the SNE and CNE. This was attributed to the chitosan decoration as well as to formulating multiple emulsions. The significant permeation and skin drug retention profile of the MNE were attributed to using the surfactants tween 80 and span 20 and the co-surfactant PEG 400. ATR-FTIR analysis confirmed that the MNE mainly affects the lipids and proteins of the skin, particularly the stratum corneum, which results in significantly higher permeation and retention of the drug. It was concluded that the proposed MNE formulation delivers drug to the target site of the skin and can be therapeutically used for various cutaneous fungal infections.

This study attempted to develop and evaluate controlled-release matrix-type transdermal patches with different ratios of hydrophilic polymers (sodium carboxymethylcellulose and hydroxypropyl methylcellulose) for the local delivery of methotrexate. Transdermal patches were formulated by employing a solvent casting technique using blends of sodium carboxymethylcellulose (CMC-Na) and hydroxypropylmethylcellulose (HPMC) polymers as rate-controlling agents. The F1 formulated patch served as the control formulation with a 1:1 polymer concentration. The F9 formulation served as our optimized formulation due to suitable physicochemical properties yielded through the combination of CMC-Na and HPMC (5:1). Drug excipient compatibilities (ATR-FTIR) were performed as a preformulation study. The ATR-FTIR study depicted great compatibility between the drug and the polymers. Physicochemical parameters, kinetic modeling, in vitro drug release, ex vivo drug permeation, skin drug retention, and in vivo studies were also carried out for the formulated patches. The formulated patches exhibited a clear, smooth, elastic nature with good weight uniformity, % moisture uptake, drug content, and thickness. Physicochemical characterization revealed folding endurance ranging from 62 ± 2.21 to 78 ± 1.54, tensile strength from 9.42 ± 0.52 to 12.32 ± 0.72, % swelling index from 37.16 ± 0.17 to 76.24 ± 1.37, and % drug content from 93.57 ± 5.34 to 98.19 ± 1.56. An increase in the concentration of the CMC-Na polymer (F9) resulted in increased drug release from the formulated transdermal patches. Similarly, drug permeation and retention were found to be higher in the F9 formulation compared to the other formulations (F1–F8). A drug retention analysis revealed that the F9 formulation exhibited 13.43% drug retention in the deep layers of the skin compared to other formulations (F1–F8). The stability study indicated that, during the study period of 60 days, no significant changes in the drug content and physical characteristics were found. ATR-FTIR analysis of rabbit skin samples treated with the formulated transdermal patches revealed that hydrophilic polymers mainly affect the skin proteins (ceramide and keratins). A pharmacokinetic profile revealed C_max was 1.77.38 ng/mL, T_max was 12 h, and t_1/2 was 17.3 ± 2.21. In vivo studies showed that the skin drug retention of F9 was higher compared to the drug solution. These findings reinforce that methotrexate-based patches can possibly be used for the management of psoriasis. This study can reasonably conclude that methotrexate transdermal matrix-type patches with CMC-Na and HPMC polymers at different concentrations effectively sustain drug release with prime permeation profiles and better bioavailability. Therefore, these formulated patches can be employed for the potential management of topical diseases, such as psoriasis.

The preparation of nickel oxide nanoparticles (NiO NPs) was carried out using an environmentally friendly and novel green synthetic strategy that included the use of Buxus wallichiana leaf extract as a reducing agent. Energy-dispersive X-ray (EDX), Fourier-transform infrared spectroscopy (FTIR), diffuse reflectance spectroscopy (DRS), X-ray diffraction (XRD), scanning electron microscope (SEM), and thermogravimetric analysis (TGA) techniques were used to characterize the resulting NiO NPs. At various concentrations, NiO NPs were tested for their percentage scavenging activity against the ABTS (2,2′-azinobis-(3-ethylbenzothiazoline-6-sulphonic acid) free radical, with an IC50 value of 234.84 g/L. Furthermore, the bactericidal activity of NiO NPs was studied by the agar well diffusion method against two Gram-positive bacterial strains (B. licheniformis and B. subtilis) and two Gram-negative bacterial strains (E. coli and K. pneumoniae).

Extraordinary Optical Transmission Plasmonic Color Filters (EOT-PCFs) with nanostructures have the advantages of consistent color, small size, and excellent color reproduction, making them a suitable replacement for colorant-based filters. Currently, the color gamut created by plasmonic filters is limited to the standard red, green, blue (sRGB) color space, which limits their use in the future. To address this limitation, we propose a surface plasmon resonance (SPR) color filter scheme, which may provide a RGB-wide color gamut while exceeding the sRGB color space. On the surface of the aluminum film, a unique nanopattern structure is etched. The nanohole functions as a coupled grating that matches photon momentum to plasma when exposed to natural light. Metals and surfaces create surface plasmon resonances as light passes through the metal film. The plasmon resonance wavelength can be modified by modifying the structural parameters of the nanopattern to obtain varied transmission spectra. The International Commission on Illumination (CIE 1931) chromaticity diagram can convert the transmission spectrum into color coordinates and convert the spectrum into various colors. The color range and saturation can outperform existing color filters.